{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:06:42Z","timestamp":1793261202057,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are aggressive pediatric brain tumors in desperate need of a curative treatment. Oncolytic virotherapy is emerging as a solid therapeutic approach. Delta-24-RGD is a replication competent adenovirus engineered to replicate in tumor cells with an aberrant RB pathway. This virus has proven to be safe and effective in adult gliomas. Here we report that the administration of Delta-24-RGD is safe in mice and results in a significant increase in survival in immunodeficient and immunocompetent models of pHGG and DIPGs. Our results show that the Delta-24-RGD antiglioma effect is mediated by the oncolytic effect and the immune response elicited against the tumor. Altogether, our data highlight the potential of this virus as treatment for patients with these tumors. Of clinical significance, these data have led to the start of a phase I\/II clinical trial at our institution for newly diagnosed DIPG (NCT03178032).<\/jats:p>","DOI":"10.1038\/s41467-019-10043-0","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:04:42Z","timestamp":1559045082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models"],"prefix":"10.1038","volume":"10","author":[{"given":"Naiara","family":"Mart\u00ednez-V\u00e9lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Garcia-Moure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Marigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Gonz\u00e1lez-Huarriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Puigdelloses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-0116","authenticated-orcid":false,"given":"Jaime","family":"Gallego P\u00e9rez-Larraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zalaca\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Marrod\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maider","family":"Varela-Guruceaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Laspidea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Javier","family":"Aristu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Isaac","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tejada-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"D\u00edez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Mart\u00ednez-Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Garc\u00eda-Barchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-7037","authenticated-orcid":false,"given":"Eric","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-237X","authenticated-orcid":false,"given":"Michelle","family":"Monje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren J.","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Pierre","family":"Junier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias A.","family":"El-Habr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-5061","authenticated-orcid":false,"given":"Herve","family":"Chneiweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Aldave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5319","authenticated-orcid":false,"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fueyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4066-8203","authenticated-orcid":false,"given":"Ana","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candelaria","family":"Gomez-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7520-7351","authenticated-orcid":false,"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"10043_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay, A. et al. Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32, 520\u2013537 (2017).","journal-title":"Cancer Cell"},{"key":"10043_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444\u2013450 (2014).","journal-title":"Nat. Genet."},{"key":"10043_CR3","first-page":"153","volume":"19","author":"C Jones","year":"2017","unstructured":"Jones, C. et al. Pediatric high-grade glioma: Biologically and clinically in need of new thinking. Neuro. Oncol. 19, 153\u2013161 (2017).","journal-title":"Neuro. Oncol."},{"key":"10043_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","journal-title":"Acta Neuropathol."},{"key":"10043_CR5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1177\/0883073809338960","volume":"24","author":"J Fangusaro","year":"2009","unstructured":"Fangusaro, J. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas. in. J. Child. Neurol. 24, 1409\u20131417 (2009).","journal-title":"J. Child. Neurol."},{"key":"10043_CR6","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro. Oncol. 18, v1\u2013v75 (2016).","journal-title":"Neuro. Oncol."},{"key":"10043_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459\u2013466 (2009).","journal-title":"Lancet Oncol."},{"key":"10043_CR8","doi-asserted-by":"crossref","unstructured":"Warren, K. E. Diffuse intrinsic pontine glioma: poised for progress. Front. Oncol. 2, 205 (2012).","DOI":"10.3389\/fonc.2012.00205"},{"key":"10043_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-017-2701-8","volume":"137","author":"C Kline","year":"2017","unstructured":"Kline, C., Felton, E., Allen, I. E., Tahir, P. & Mueller, S. Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis. J. Neurooncol. 137, 103\u2013110 (2017).","journal-title":"J. Neurooncol."},{"key":"10043_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-017-2546-1","volume":"135","author":"H Hassan","year":"2017","unstructured":"Hassan, H., Pinches, A., Picton, S. V. & Phillips, R. S. Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis. J. Neurooncol. 135, 13\u201320 (2017).","journal-title":"J. Neurooncol."},{"key":"10043_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.seminoncol.2016.10.005","volume":"43","author":"C Grigg","year":"2016","unstructured":"Grigg, C. et al. Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers. Semin. Oncol. 43, 638\u2013646 (2016).","journal-title":"Semin. Oncol."},{"key":"10043_CR12","first-page":"120","volume":"7","author":"K Suzuki","year":"2001","unstructured":"Suzuki, K. et al. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin. Cancer Res. 7, 120\u2013126 (2001).","journal-title":"Clin. Cancer Res."},{"key":"10043_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","volume":"95","author":"J Fueyo","year":"2003","unstructured":"Fueyo, J. et al. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J. Natl. Cancer Inst. 95, 652\u2013660 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"10043_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang, F. F. et al. Phase I Study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J. Clin. Oncol. 36, 1419\u20131427 (2018).","journal-title":"J. Clin. Oncol."},{"key":"10043_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/neuros\/nyx507","volume":"83","author":"S Tejada","year":"2017","unstructured":"Tejada, S. et al. Phase I Trial of DNX-2401 for diffuse intrinsic pontine glioma newly diagnosed in pediatric patients. Neurosurgery 83, 1050\u20131056 (2017).","journal-title":"Neurosurgery"},{"key":"10043_CR16","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RH Andtbacka","year":"2015","unstructured":"Andtbacka, R. H. et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780\u20132788 (2015).","journal-title":"J. Clin. Oncol."},{"key":"10043_CR17","doi-asserted-by":"crossref","unstructured":"Halvorson, K. G. et al. A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent. PLoS ONE 10, e0118926 (2015).","DOI":"10.1371\/journal.pone.0118926"},{"key":"10043_CR18","doi-asserted-by":"crossref","unstructured":"Barton, K. L. et al. PD-0332991, a CDK4\/6 Inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS ONE 8, e77639 (2013).","DOI":"10.1371\/journal.pone.0077639"},{"key":"10043_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0168-1702(89)90026-9","volume":"14","author":"GE Blair","year":"1989","unstructured":"Blair, G. E., Dixon, S. C., Griffiths, S. A. & Zajdel, M. E. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res. 14, 339\u2013346 (1989).","journal-title":"Virus Res."},{"key":"10043_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/mt.2014.22","volume":"22","author":"JM Markert","year":"2014","unstructured":"Markert, J. M. et al. A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol. Ther. 22, 1048\u20131055 (2014).","journal-title":"Mol. Ther."},{"key":"10043_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMoa1716435","volume":"379","author":"A Desjardins","year":"2018","unstructured":"Desjardins, A. et al. Recurrent glioblastoma treated with recombinant poliovirus. N. Engl. J. Med. 379, 150\u2013161 (2018).","journal-title":"N. Engl. J. Med."},{"key":"10043_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/neuonc\/nov123","volume":"18","author":"GK Friedman","year":"2016","unstructured":"Friedman, G. K. et al. Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses. Neuro. Oncol. 18, 227\u2013235 (2016).","journal-title":"Neuro. Oncol."},{"key":"10043_CR23","doi-asserted-by":"crossref","unstructured":"Studebaker, A. W. et al. Oncolytic herpes virus rRp450 shows efficacy in orthotopic xenograft group 3\/4 medulloblastomas and atypical teratoid\/rhabdoid tumors. Mol. Ther. Oncolytics 6, 22\u201330 (2017).","DOI":"10.1016\/j.omto.2017.05.005"},{"key":"10043_CR24","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/neuonc\/nov058","volume":"17","author":"AW Studebaker","year":"2015","unstructured":"Studebaker, A. W. et al. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Neuro. Oncol. 17, 1568\u20131577 (2015).","journal-title":"Neuro. Oncol."},{"key":"10043_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/OV.S96932","volume":"5","author":"AM Waters","year":"2016","unstructured":"Waters, A. M., Friedman, G. K., Ring, E. K. & Beierle, E. A. Oncolytic virotherapy for pediatric malignancies: future prospects. Oncolytic Virother. 5, 73\u201380 (2016).","journal-title":"Oncolytic Virother."},{"key":"10043_CR26","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1158\/1078-0432.CCR-16-2900","volume":"23","author":"KA Streby","year":"2017","unstructured":"Streby, K. A. et al. Intratumoral injection of HSV1716, an oncolytic herpes virus, is safe and shows evidence of immune response and viral replication in young cancer patients. Clin. Cancer Res. 23, 3566\u20133574 (2017).","journal-title":"Clin. Cancer Res."},{"key":"10043_CR27","doi-asserted-by":"crossref","unstructured":"Cockle, J. V. et al. Oncolytic herpes simplex virus inhibits pediatric brain tumor migration and invasion. Mol. Ther. Oncolytics 5, 75\u201386 (2017).","DOI":"10.1016\/j.omto.2017.04.002"},{"key":"10043_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","volume":"15","author":"FJ Cordero","year":"2017","unstructured":"Cordero, F. J. et al. Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG. Mol. Cancer Res. 15, 1243\u20131254 (2017).","journal-title":"Mol. Cancer Res."},{"key":"10043_CR29","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-15-2157","volume":"76","author":"GJ Rahme","year":"2016","unstructured":"Rahme, G. J. et al. PDGF engages an E2F-USP1 signaling pathway to support ID2-mediated survival of proneural glioma cells. Cancer Res. 76, 2964\u20132976 (2016).","journal-title":"Cancer Res."},{"key":"10043_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.WNL.0000133302.15022.7F","volume":"63","author":"C Gomez-Manzano","year":"2004","unstructured":"Gomez-Manzano, C., Yung, W. K. A., Alemany, R. & Fueyo, J. Genetically modified adenoviruses against gliomas: from bench to bedside. Neurology 63, 418\u2013426 (2004).","journal-title":"Neurology"},{"key":"10043_CR31","doi-asserted-by":"crossref","unstructured":"Misuraca, K. L., Cordero, F. J. & Becher, O. J. Pre-clinical models of diffuse intrinsic pontine glioma. Front. Oncol. 5, 172 (2015).","DOI":"10.3389\/fonc.2015.00172"},{"key":"10043_CR32","doi-asserted-by":"crossref","unstructured":"Jiang, H. et al. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS ONE 9, e97407 (2014).","DOI":"10.1371\/journal.pone.0097407"},{"key":"10043_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00415-017-8695-5","volume":"265","author":"JT Miyauchi","year":"2018","unstructured":"Miyauchi, J. T. & Tsirka, S. E. Advances in immunotherapeutic research for glioma therapy. J. Neurol. 265, 741\u2013756 (2018).","journal-title":"J. Neurol."},{"key":"10043_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ccell.2017.03.002","volume":"31","author":"RG Majzner","year":"2017","unstructured":"Majzner, R. G., Heitzeneder, S. & Mackall, C. L. Harnessing the immunotherapy revolution for the treatment of childhood cancers. Cancer Cell 31, 476\u2013485 (2017).","journal-title":"Cancer Cell"},{"key":"10043_CR35","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/1078-0432.CCR-15-0491","volume":"22","author":"MS Merchant","year":"2016","unstructured":"Merchant, M. S. et al. Phase I clinical trial of ipilimumab in pediatric patients with advanced solid tumors. Clin. Cancer Res. 22, 1364\u20131370 (2016).","journal-title":"Clin. Cancer Res."},{"key":"10043_CR36","doi-asserted-by":"crossref","unstructured":"Bonifant, C. L., Jackson, H. J., Brentjens, R. J. & Curran, K. J. Toxicity and management in CAR T-cell therapy. Mol. Ther. Oncolytics 3, 16011 (2016)","DOI":"10.1038\/mto.2016.11"},{"key":"10043_CR37","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1172\/JCI119110","volume":"98","author":"MG Wing","year":"1996","unstructured":"Wing, M. G. et al. Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (Fc\u03b3RIII) and CD11a\/CD18 (LFA-1) on NK cells. J. Clin. Invest. 98, 2819\u20132826 (1996).","journal-title":"J. Clin. Invest."},{"key":"10043_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","volume":"385","author":"DW Lee","year":"2015","unstructured":"Lee, D. W. et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet 385, 517\u2013528 (2015).","journal-title":"Lancet"},{"key":"10043_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/mt.2010.24","volume":"18","author":"RA Morgan","year":"2010","unstructured":"Morgan, R. A. et al. Case report of a serious adverse event following the administration of t cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18, 843\u2013851 (2010).","journal-title":"Mol. Ther."},{"key":"10043_CR40","doi-asserted-by":"crossref","unstructured":"Tejada, S. et al. DNX-2401, an oncolytic virus, for the treatment of newly diagnosed diffuse intrinsic pontine gliomas: a case report. Front. Oncol. 8, 61 (2018).","DOI":"10.3389\/fonc.2018.00061"},{"key":"10043_CR41","doi-asserted-by":"crossref","unstructured":"Alonso M. M., et al. Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: clinical data and prognostic biomarkers. in Proceedings of the American Association for Cancer Research Annual Meeting 2017 . 77 (13 Suppl) (2017).","DOI":"10.1158\/1538-7445.AM2017-CT027"},{"key":"10043_CR42","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/hum.2006.17.929","volume":"17","author":"M Cascallo","year":"2006","unstructured":"Cascallo, M. et al. Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses. Hum. Gene Ther. 17, 929\u2013940 (2006).","journal-title":"Hum. Gene Ther."},{"key":"10043_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"10043_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3171\/jns.2000.92.2.0326","volume":"92","author":"S Lal","year":"2000","unstructured":"Lal, S. et al. An implantable guide-screw system for brain tumor studies in small animals. J. Neurosurg. 92, 326\u2013333 (2000).","journal-title":"J. Neurosurg."},{"key":"10043_CR45","doi-asserted-by":"crossref","unstructured":"Marigil, M. et al. Development of a DIPG orthotopic model in mice using an implantable guide-screw system. PLoS ONE 12, (2017).","DOI":"10.1371\/journal.pone.0170501"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10043-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T18:44:10Z","timestamp":1671216250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10043-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10043"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10043-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.J., C.G.-M. and J.F. report ownership interest (including patents) in and are consultants for DNATrix. M.M.A., S.T.-S. and R.D.-V. report DNAtrix sponsored research not related with this article. The remaining authors do not have potential conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2235"}}